close
close
Latest

Pliant Therapeutics: Latest Financials Support Stable Investment In Future Growth (PLRX)

Scientist working in the laboratory

sanjeri/E+ via Getty Images

Pliant Therapeutics (NASDAQ:PLRX) is a clinical-stage biotech company that researches and develops novel therapeutics for the treatment of fibrosis and other conditions. Its diverse pipeline includes PLN-74809, an orally administered inhibitor of thePLN-1474PLN-101095

RD SGA Expenses Chart

YCharts.com

Cash and Net Income Chart

YCharts.com

Read  Pacifier Market (Latest Report) is Anticipated to Undergo
Pipeline

r.pliantrx.com

Read  Rangers or Vitali Kravtsov? Who is to blame for latest fallout of former 1st rounder?
Bexotegrast Mechanism

r.pliantrx.com

INTEGRIS-IPF Study Design

r.pliantrx.com

Read  The Drum | Oooft! Tennent’s Pours Seven Figures Into Latest Ad Campaign

Source

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button